Third-generation cephalosporins have broad-spectrum microbiologic acti
vity, a low incidence of adverse effects, and proven clinical efficacy
for a wide variety of infections. No single cephalosporin is useful f
or all clinical situations because cephalosporins differ in their gram
-positive, gram-negative, and anaerobic spectrum, serum half-life, pen
etration of cerebrospinal fluid, and beta-lactamase resistance. Cefota
xime and ceftizoxime have the best gram-positive activity of the third
-generation agents whereas ceftazidime, with its long half-life, can b
e dosed once daily and is useful for outpatient antibiotic therapy.